Alan Hutchinson Fairlamb
Directeur/Membre du Conseil chez Tres Cantos Open Lab Foundation
Provenance du réseau au premier degré de Alan Hutchinson Fairlamb
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Tres Cantos Open Lab Foundation
 Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alan Hutchinson Fairlamb via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chief Executive Officer | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
| Brown University | College/University | Undergraduate Degree | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| ABBOTT INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Hudson-Douglas Ltd. | President | ||
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Knoll Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | ||
| University of Cambridge | College/University | Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
Hospital for Special Surgery
 Hospital for Special Surgery Hospital/Nursing ManagementHealth Services Hospital for Special Surgery provides healthcare services. Its services include orthopedic, rheumatology, and rehabilitation specific surgery services. The company was founded by James A. Knight and Robert M. Hartley in 1863 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 10 |
| Royaume-Uni | 3 |
| Inde | 2 |
| Allemagne | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 12 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Melvin Spigelman | 11 |
| Timothy Wells | 4 |
| Carl F. Nathan | 2 |
| Kip Guy | 1 |
| Jose Maria Romero | 1 |
| Graeme Bilbe | 1 |
| Elizabeth Winzeler | 1 |
- Bourse
- Insiders
- Alan Hutchinson Fairlamb
- Connexions Sociétés
